$科笛-B.HKIPO 前已经完成了三轮融资,最近的一轮融资在 2021 年 9 月,融资成本价较这次 IPO 发行价折 9%,看似溢价率不高,但是 2021 年的生物 B 估值是严重有水分的。不准备申购了。

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Like